TICKERNERD
Menu
HUMHUMHealthcare · Healthcare Plans

HUM Stock Forecast: Humana, Inc. Price Predictions for 2026-2027

Last close, 6 Aug 2026
$367
+0.96% on the day

The 26 Wall Street analysts covering Humana, Inc. hold a median 12-month price target of $415 — +13.0% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 43 of 100 as at 6 Aug 2026 — in the lower half.

Market cap
$43.5B
Ticker Nerd rank
43 / 100
Median analyst target
$415
Analysts covering
26
Total return, dividends reinvested
1W
+0.2%
1M
−6.5%
YTD
+44.5%
1Y
+45.2%
From 52W high
−10.3%
From 52W low
+126.1%
$162
$409
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

HUM stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Humana, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 6 Aug 2026
43 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Momentum
87
Volatility
72
Value
66
Issuance
53
Growth
52
Revisions
49
Quality
36
Accruals
34
Size
6

Momentum (87): The shares have been drifting up relative to others.

Accruals (34): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Size (6): Larger than most of the companies we track — more scrutinised, less often mispriced.

The rank is the raw material. Whether the rules would actually own Humana, Inc. — and when they’d sell — is the membership.

Wall Street

HUM stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on HUM, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$100$200$300$400$500Oct 25Jan 26Apr 26Jul 26HUMHigh $513Median $415Low $249

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says26 analysts
12 Buy12 Hold2 Sell
Low $249Median $415High $513

The green dot is the last close — the median target sits +13.0% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 11 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
5 Aug 2026Morgan StanleyUpgradeEqual-Weight$249 → $370
31 July 2026BarclaysMaintainsEqual-Weight$344 → $407
31 July 2026TD CowenMaintainsHold$350 → $370
30 July 2026Evercore ISI GroupUpgradeOutperform$430 → $480
30 July 2026GuggenheimMaintainsBuy$269 → $471
30 July 2026Raymond JamesDowngradeMarket Perform—
30 July 2026UBSMaintainsNeutral$320 → $405
14 July 2026TD CowenMaintainsHold$211 → $350
14 July 2026TD CowenMaintainsHold—
14 July 2026Truist SecuritiesMaintainsHold$320 → $415
14 July 2026Truist SecuritiesMaintainsHold—
13 July 2026Wells FargoUpgradeOverweight$227 → $502
13 July 2026Wells FargoUpgradeOverweight—
9 July 2026RBC CapitalMaintainsSector Perform—
9 July 2026RBC CapitalMaintainsSector Perform$246 → $415
7 July 2026Cantor FitzgeraldMaintainsNeutral$264 → $300
7 July 2026Cantor FitzgeraldMaintainsNeutral—
24 June 2026B of A SecuritiesMaintainsNeutral—
11 June 2026Evercore ISI GroupMaintainsIn-Line—
8 June 2026JP MorganMaintainsNeutral—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

HUM analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+3.5%
Analysts raising
4
Analysts cutting
0
Fundamentals

Humana, Inc. (HUM) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
34.4×

Cheaper than 24% of US stocks

Price / sales
0.3×

Cheaper than 89% of US stocks

Price / book
2.3×

Cheaper than 43% of US stocks

EV / EBITDA
10.0×

Cheaper than 39% of US stocks

Growth & margins
Revenue growth (YoY)
26.2%

Higher than 77% of US stocks

Earnings growth (YoY)
27.3%

Higher than 67% of US stocks

Gross margin
—
Operating margin
3.5%

Higher than 54% of US stocks

Net margin
0.9%

Higher than 49% of US stocks

Returns & dividend
Return on equity
6.9%

Higher than 57% of US stocks

Return on assets
3.9%

Higher than 71% of US stocks

Dividend yield
1.0%

Higher than 22% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

HUM vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealthcare Plans
CompanyMarket capTKN rank
HUMHumana, Inc.$43.5B
43
CNCCentene Corp.$31.6B
91
CIThe Cigna Group$72.7B
69
ELVElevance Health, Inc.$87.0B
63
CVSCVS Health Corp.$122.1B
86
MOHMolina Healthcare, Inc.$9.9B
31
OSCROscar Health, Inc.$7.9B
78
Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. HUM appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

News

Latest HUM news & analysis

Diamond Hill Small-Mid Cap Fund Q2 2026 Portfolio Review

Seeking Alpha · 7 Aug 2026neutral

Diamond Hill Small-Mid Cap Fund's Q2 2026 portfolio review reported a 9.71% gain versus a 20.26% rise for the Russell 2500 Index. The fund initiated a position in managed care provider Centene and sold Wix.com amid slowing growth tied to AI-driven coding tools.

Why it matters — A Humana watcher would note the fund's new stake in managed care peer Centene as an indicator of investor positioning in that sector, though Humana itself is not directly mentioned.

This Humana Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday

Benzinga · 5 Aug 2026positive

A top Wall Street analyst changed their outlook on Humana from bearish to bullish, and the company was listed among the top five analyst upgrades for Wednesday.

Why it matters — An analyst upgrading Humana from bearish to bullish signals a shift in expert sentiment that could influence investor perception of the stock.

Humana Community Day 2026 Mobilizes Thousands of Employees Nationwide to Support Healthier Communities

Business Wire · 4 Aug 2026positive

Humana announced its 2026 Community Day, an annual nationwide service event scheduled for August 26, 2026, that will mobilize thousands of employees to volunteer in communities across the U.S., focusing on food insecurity, neighborhood revitalization, and social connection.

Why it matters — The initiative highlights Humana's commitment to community health and employee engagement, reinforcing its brand as a health-focused company beyond insurance products.

This Humana Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Benzinga · 30 July 2026negative

Benzinga reported that a Humana analyst changed their outlook on the company from bullish, listing the downgrade among the top five analyst downgrades for Thursday.

Why it matters — HUM watchers would care because a top Wall Street analyst turning bearish on the stock could influence market sentiment and other analysts' views on the company.

FAQ

Frequently asked questions about HUM stock

What is the HUM stock price forecast for 2026-2027?

The 26 Wall Street analysts covering Humana, Inc. have a median 12-month price target of $415, with estimates ranging from $249 to $513. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is HUM stock a buy right now?

Of the 26 analysts covering Humana, Inc., 12 rate it a Buy, 12 a Hold and 2 a Sell. Ticker Nerd's systematic factor model ranks Humana, Inc. 43 out of 100 across roughly 4,600 US stocks as at 6 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank HUM?

As at 6 Aug 2026, Humana, Inc. ranks 43 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (87 of 100).

Will HUM stock go up?

No one can know that. What the data says: the median 12-month target from 26 analysts implies +13.0% from the last close, and Ticker Nerd's factor model ranks Humana, Inc. 43 out of 100 as at 6 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the HUM stock forecast for 2030?

No analyst covering Humana, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HUM are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $249 to $513 over the next 12 months.

How has HUM stock performed over the past year?

Humana, Inc. returned +45.2% over the 12 months to 6 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Humana, Inc. do?

Humana Inc. is a U.S.-based health insurance and healthcare services company headquartered in Louisville, Kentucky.

What is the latest news on HUM?

The most recent item we track (Seeking Alpha, 7 Aug 2026): "Diamond Hill Small-Mid Cap Fund Q2 2026 Portfolio Review". Diamond Hill Small-Mid Cap Fund's Q2 2026 portfolio review reported a 9.71% gain versus a 20.26% rise for the Russell 2500 Index. The fund initiated a position in managed care provider Centene and sold Wix.com amid slowing growth tied to AI-driven coding tools.

Company

About Humana, Inc.

Humana Inc. is a U.S.-based health insurance and healthcare services company headquartered in Louisville, Kentucky. The company focuses on providing medical and specialty insurance products, with a particular emphasis on Medicare-related offerings for seniors, including individual and group Medicare Advantage plans, stand-alone prescription drug plans, Medicare supplement policies, and ancillary coverage such as dental, vision, life, and disability insurance. Humana also administers healthcare services for military members, retirees, and their families through administrative service contracts. Through its CenterWell segment, Humana operates senior-focused primary care centers, home health services, and pharmacy and hospice solutions, integrating clinical care with insurance to support coordinated, value-based care. By combining insurance products with direct healthcare delivery capabilities, Humana plays a significant role in the managed healthcare sector, serving individuals, employers, and government-sponsored programs across the United States.

CEO Mr. James A. Rechtin M.B.A. · 67,060 employees · United States · https://www.humana.com